Combined results suggest that IGF-1 levels are significantly increased in MDD patients compared to healthy controls (SMD: 0.56; 95%CI: 0.34, 0.78; p<0.00001), with high heterogeneity (I2 = 81%; p<0.00001) (Figure 2). The gene discussed is IGF1; the disease is major depressive disorder.